183 related articles for article (PubMed ID: 2558827)
1. CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.
Stewart AG
Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):813-20. PubMed ID: 2558827
[TBL] [Abstract][Full Text] [Related]
2. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
Stewart AG; Dusting GJ
Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
[TBL] [Abstract][Full Text] [Related]
3. Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.
Stewart AG; Phillips WA
Br J Pharmacol; 1989 Sep; 98(1):141-8. PubMed ID: 2553184
[TBL] [Abstract][Full Text] [Related]
4. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
Morris DD; Moore JN
Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
6. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Floch A; Tahraoui L; Sedivy P; Cavero I
J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
[TBL] [Abstract][Full Text] [Related]
7. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
8. Biological response of guinea pig peritoneal macrophages to platelet-activating factor.
Hayashi H; Kudo I; Nojima S; Inoue K
Lipids; 1991 Dec; 26(12):1193-9. PubMed ID: 1668117
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
Stewart AG; Grigoriadis G
J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
Terashita Z; Imura Y; Nishikawa K
Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation reduces mobilization of arachidonic acid by guinea-pig and rat peritoneal macrophages in vitro.
Lim WH; Stewart AG
Agents Actions; 1990 Nov; 31(3-4):290-7. PubMed ID: 2128165
[TBL] [Abstract][Full Text] [Related]
12. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
13. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.
Takahashi S; Yoshikawa T; Naito Y; Tanigawa T; Yoshida N; Kondo M
Lipids; 1991 Dec; 26(12):1227-30. PubMed ID: 1668119
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X; Han GQ; Li RZ
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):672-6. PubMed ID: 2983307
[TBL] [Abstract][Full Text] [Related]
15. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.
Stewart AG; Dubbin PN; Harris T; Dusting GJ
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3215-9. PubMed ID: 2158106
[TBL] [Abstract][Full Text] [Related]
18. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.
Shimada T; Hirose T; Matsumoto I; Aikawa T
J Endocrinol; 2005 Feb; 184(2):381-91. PubMed ID: 15684346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]